oloBion is a multi-omics CRO providing specialized metabolomics, lipidomics, and proteomics services. Combining advanced mass spectrometry with its AI-powered oloMAP platform, it supports global research and drug discovery initiatives.
oloBion is a science-based Contract Research Organization (CRO) specializing in multi-omics analytical services, including metabolomics, lipidomics, and proteomics. Operating from facilities in the Barcelona Scientific Park and the University of California, Davis, the company utilizes advanced mass spectrometry platforms and proprietary AI-powered bioinformatics software, known as oloMAP, to process and interpret complex biological data. Their end-to-end workflows span from sample preparation to the delivery of actionable scientific insights, supporting research and development across sectors such as pharmaceuticals, biotechnology, biomedical health, agriculture, and nutrition. By integrating robust analytical methodologies with systems biology expertise, oloBion provides high-confidence data for molecular characterization, biomarker identification, and the assessment of biochemical impacts in biological systems.
The company serves a global client base across academia and industry, focusing on accelerating discovery, ensuring drug safety, and identifying new therapeutic targets. Its services are designed to address the needs of researchers conducting exploratory studies or applied innovation programs, offering tailored workflows that translate raw omics data into clear biological outcomes. Through strategic collaborations, such as those with the Institute for Research in Biomedicine (IRB Barcelona), oloBion contributes to advancements in cancer research and metabolic studies, demonstrating the clinical and translational value of its multi-omics approach. By leveraging its technological infrastructure and scientific leadership, oloBion functions as a long-term partner for organizations seeking to navigate the complexity of omics data for evidence-based decision-making.